Successful recovery of a patient with multiple myeloma from severe coronavirus disease 2019 (COVID‑19) pneumonia during the first chemotherapy cycle: A case report
Authors:
- 24 February 2021
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (4) , 1-5
Abstract
A continuing outbreak of pneumonia associated with the 2019 novel coronavirus (2019‑nCoV) was initially described in Wuhan, China in December 2019. Weak and elderly individuals, and those with chronic diseases such as hematological malignancies are prone to develop severe pneumonia. The humoral immunity of patients with multiple myeloma is prevalently low, and their inferior immunity further deteriorates during chemotherapy. For patients with onco‑hematological malignancies infected with 2019‑nCoV during the first chemotherapy cycle, the clinical treatment experience is lacking. The present study is a report of a 61‑year‑old patient newly diagnosed with multiple myeloma in the key 2019‑nCoV outbreak area, who suffered severe 2019‑nCoV pneumonia during the first chemotherapy cycle. The present case report demonstrated that a rapidly progressive and severe form of pneumonia was a specific clinical feature of COVID‑19, especially in immunocompromised patients with cancer. The treatment strategy combining timely suspending chemotherapy, early intervention using intravenous immunoglobulin, interferon α inhalation and oral antiviral drugs was effective. Therefore, in the pandemic environment, it is strongly recommend that the risk of 2019‑nCoV infection is assessed prior to chemotherapy.Keywords
This publication has 15 references indexed in Scilit:
- Global Burden of Multiple MyelomaJAMA Oncology, 2018
- Immunologic approaches for the treatment of multiple myelomaCancer Treatment Reviews, 2017
- Multiple myeloma epidemiology and survival: A unique malignancySeminars in Oncology, 2016
- 2016 US lymphoid malignancy statistics by World Health Organization subtypesCA: A Cancer Journal for Clinicians, 2016
- Daratumumab, Bortezomib, and Dexamethasone for Multiple MyelomaNew England Journal of Medicine, 2016
- Influenza virus-induced lung injury: pathogenesis and implications for treatmentEuropean Respiratory Journal, 2015
- The role of influenza in the severity and transmission of respiratory bacterial diseaseThe Lancet Respiratory Medicine, 2014
- Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infectionThe Lancet Infectious Diseases, 2013
- Bacterial Coinfection in InfluenzaJAMA, 2013
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975